| No. of patients | Week 4 | Week 12 | Week 24 | Week 48 | SVR | ||
|---|---|---|---|---|---|---|---|
| Total | 26 | 96.15% | 92.31% | 92.31% | 88.46% | 84.62% | |
| Telaprevir | 19 | 94.74% | 89.47% | 89.47% | 89.47% | 84.21% | |
| Boceprevir | 7 | 100% | 100% | 100% | 85.71% | 85.71% | |
| Naive | 10 | 100% | 100% | 100% | 90% | 90% | |
| Previously-Treated | 16 | 93.75% | 87.50% | 87.50% | 87.50% | 81.25% | |
| Relapsers | 8 | 100% | 100% | 100% | 100% | 100% | |
| Partial Response | 7 | 87.50% | 75.00% | 75.00% | 75.00% | 62.50% | |
| Null Responders | 1 | 100% | 100% | 100% | 100% | 100% | |